On March 1, 2024, experts from the Suzhou Municipal Bureau of Agriculture and Rural Affairs visited for an inspection. Our company successfully passed the qualification review for Jiangsu Province's certification as a quarantine and testing laboratory specializing in dogs and cats at their place of origin.

Image Name

2024.03.01

[Suzhou, March 1, 2024] Today, a delegation of experts from the Suzhou Municipal Bureau of Agriculture and Rural Affairs visited our company to conduct a comprehensive and meticulous inspection and evaluation of Jiangsu Province’s Canine and Feline Production Quarantine Testing Laboratory. After rigorous review, our laboratory successfully passed the acceptance process, marking another authoritative recognition of the company’s professional expertise and standardized management in the field of animal disease testing.

The expert panel conducted a comprehensive assessment of our company’s laboratory—including its facilities and equipment, testing procedures, quality management system, and staff qualifications—through on-site inspections, document reviews, and technical inquiries. The inspection team highly praised our company’s advanced technical standards, standardized operational processes, and rigorous quality control measures. They unanimously concluded that the laboratory meets the relevant requirements for origin quarantine testing of dogs and cats in Jiangsu Province and approved its successful acceptance.

This successful inspection not only highlights our company's professional expertise in the field of animal quarantine and testing, but also provides robust technical support for safeguarding pet health and promoting high-quality development in the livestock industry. Moving forward, our company will continue to uphold a scientific and rigorous approach, constantly enhancing our testing capabilities to contribute to the healthy growth of the industry.

 

 

West Mountain

Previous article

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

On August 14, 2023, our company successfully passed the CNAS re-evaluation and on-site assessment for scope expansion.

Next article

Previous article

On August 14, 2023, our company successfully passed the CNAS re-evaluation and on-site assessment for scope expansion.

Next article

On August 14, 2023, our company successfully passed the CNAS re-evaluation and on-site assessment for scope expansion.

More information

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

[Suzhou, May 10, 2025] Recently, our company’s Nano Park facility successfully completed the filing process for its P2 laboratory with the Suzhou Municipal Bureau of Agriculture and Rural Affairs, officially becoming one of the first animal pathogen microbiology laboratories in the entire Suzhou metropolitan area to receive approval under the newly implemented "Jiangsu Province Animal Pathogen Microbiology Laboratory Filing Management Measures" (effective February 1, 2025).

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

Recently, our company successfully passed the on-site expansion review for CMA accreditation, marking official recognition from a national authority of our professional expertise and robust quality management system in the field of laboratory animal testing. The review took place from September 1 to September 2, 2024, during which the expert panel conducted a comprehensive and rigorous assessment of our laboratory animal testing technologies, equipment, personnel, and management systems—ultimately confirming that we meet the relevant CMA standards.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024 – Our company has officially obtained the Veterinary Drug Production License and the Veterinary Drug GMP Certificate issued by the Ministry of Agriculture and Rural Affairs, marking that our company’s quality management system and technical capabilities in the veterinary drug manufacturing sector have met the nation’s stringent high-standard requirements. During this certification process, our immunology-based diagnostic product (Class B) production line successfully passed the on-site GMP inspection for veterinary drugs and was recognized as a qualified production line, laying a solid foundation for the company to further expand into the veterinary diagnostic reagent market.